Recruiting Pulmonary Embolism Studies in Fullerton
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investigated in participants with type 1 diabetes. The stu...
Secukinumab Open Label Roll-over Extension Protocol
The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the investigator to benefit from continued treatment w...
About Pulmonary Embolism Clinical Trials in Fullerton
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Fullerton, CA. These studies are seeking a combined 1,592 participants. Research is being sponsored by Novo Nordisk A/S, Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Fullerton — FAQ
Are there pulmonary embolism clinical trials in Fullerton?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Fullerton, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fullerton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fullerton research site will contact you about next steps.
Are clinical trials in Fullerton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fullerton studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Fullerton are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov